Information  X 
Enter a valid email address

OMV Petrom S.A. (PETB)

  Print      Mail a friend

Wednesday 30 October, 2019

OMV Petrom S.A.

Results for January-September and Q3 2019

RNS Number : 5905R
OMV Petrom S.A.
30 October 2019
 

OMV Petrom Group results for January - September and Q3 2019 

including unaudited interim condensed consolidated financial statements as of and for the period ended September 30, 2019

 

Highlights Q3/19 vs Q3/18

Group

u Clean CCS Operating Result at RON 1.2 bn, 27% lower

u Clean CCS net income attributable to stockholders at RON 1.0 bn, down 26%

u Cash flow from operating activities at RON 2.1 bn, 12% lower

u CAPEX at RON 1.1 bn, up 8%

u Clean CCS ROACE at 14.7%, 3 pp higher

Upstream

u Clean Operating Result at RON 546 mn, down 43%, mainly driven by lower oil prices and hydrocarbon volumes

u Production decreased by 6.2%, mostly due to natural decline and the transfer of marginal fields

u OPEX at USD 10.45/boe, stable

Downstream Oil

u Clean CCS Operating Result at RON 580 mn, 7% higher, capturing increased demand for refined products and excellent operational performance

u OMV Petrom indicator refining margin at USD 6.46/bbl, down 2%

u Refinery utilization rate at 99%; retail volumes up 4%

Downstream Gas

u Clean Operating Result at RON 57 mn, down 40% (Q3/18 included Brazi power plant insurance revenues)  

u Gas sales volumes up 37% yoy, built on third-party supply; net electrical output at 1.00 TWh, stable

u OMV Petrom supplies the gas and power regulated markets; 4.47 TWh of gas were delivered in Q3/19 to the households and district heating for households suppliers and 0.48 TWh to the power regulated market suppliers, as per the set allocations

 

 

Please access the link here below to view the full report.

http://www.rns-pdf.londonstockexchange.com/rns/5905R_1-2019-10-30.pdf

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
QRTGUBDGCUXBGCG

a d v e r t i s e m e n t